As of 2024-12-14, the Fair Value of Cytosorbents Corp (CTSO) is -1.71 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 1.01 USD, the upside of Cytosorbents Corp is -269.03%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -19.27 | -7.84 | -24.56 | -32.81 | -28.51 | -22.60 |
| YoY growth | -11.97% | 59.31% | -213.27% | -33.59% | 13.11% | -37.28% |
| Market Cap (mil) | 55.23 |
| P/E | |
| Forward P/E |
| EPS | -0.34 |
| Avg earnings growth rate | -37.28% |
| TTM earnings | -18.67 |